* TherapeuticsMD announces positive top-line results from
pivotal phase 3 replenish trial in postmenopausal women with
moderate to severe vasomotor symptoms (vms) treated with
tx-001hr
The post BRIEF-TherapeuticsMD reports positive top-line results from pivotal phase 3 replenish trial in postmenopausal women with moderate to severe vasomotor symptoms (vms) treated with tx-001hr appeared first on NASDAQ.